ANGELA HORNAK: Open Payments
NPI 1083835334 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 9 payments from 6 companies in 2025. Trend: 2023 $166 · 2024 $64 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| ABBVIE INC. | 1 | $15 |
| Boston Scientific Corporation | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: Veozah, MOUNJARO, SHINGRIX, QULIPTA, TRELEGY ELLIPTA, WaveWriter Alpha Prime 16, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
